23andMe Inc. (ME): Earnings per share for the last twelve months

Official company branding of 23andMe Inc (ME)

23andMe Holding Co. (ME) maintains a resilient business model due to US data localization, which eliminates external pressure. The rolling net income per share on the GURU.Markets chart has stabilized at -15.81. Unique patents and strict FDA oversight ensure the company's dominance. 23andMe Holding Co. (ME) generates revenue through the sale of genetic tests and by providing the largest pharmaceutical behemoths with access to its biobank.

ME (23andMe Holding Co.) Net earnings per share (EPS TTM) history from 07/04/2022 to 04/05/2025

Financial and market metric breakdowns for 23andMe Inc (ME)

- current quotes and average value forecast:
Initial company analysis:23andMe Inc (ME)
Manufactured products of 23andMe Inc.

Separating stable assets from speculative instruments requires an analysis of the actual yield per security. For 23andMe Holding Co. (ME), this process is complicated by the intensive liquidity burn associated with biotechnological research. The annual net income per share trend measures the final financial result for the year divided by the number of shares. This metric reveals the business's actual ability to generate value. Current price action confirms a critical depletion of the company's reserves.

Main competitors

agilent.com - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Quest Diagnostics Inc. DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months revvity.com|Earnings per share for the last twelve months BIO|Net earnings per share (EPS TTM) NNNN|SHC - Net earnings per one share for the last twelve months|Quidel Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Corp. OPK|CDNA - Earnings per share for the last twelve months|Earnings per share for the trailing year MRVI (Maravai LifeSciences)|FLGT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LAB|Earnings per share for the last twelve months Cytek Biosciences Inc|Net earnings per share (EPS TTM) OraSure Corp|Net earnings per share for the last 12 months XGN (Exagen Inc)|Net earnings per share (EPS TTM) mdxhealth.com (MDXH)|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc)|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|viraxbiolabs.com - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|PMD - Net earnings per one share for the last twelve months